Skip to content

Supporting Lifestyle Changes After Delivery

Information and Communication Technology -Based Health Behavior Change Support System to Modify Lifestyle After Delivery: Randomized Controlled Intervention Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06241144
Acronym
STELLA
Enrollment
200
Registered
2024-02-05
Start date
2024-02-09
Completion date
2032-12-31
Last updated
2024-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lifestyle, Obesity, Maternal

Brief summary

Use of information and communication technology -based health behavior change support system in modifying lifestyle after delivery among women with obesity.

Detailed description

Postpartum weight retention is common and particular when accompanied with prior obesity, it further increases the risks of subsequent pregnancies and adverse effects on the long-term health. The aim of this randomized controlled trial is to examine whether using an information and communication technology (ICT) -based health behavior change support system (HBCSS) reduce postpartum weight retention and disorders related to subsequent pregnancy. Web-based HBCSS application utilizes persuasive design and cognitive behavioral therapy. 200 participants with prepregnancy obesity (BMI ≥ 30.0 kg/m\^2) and age ≥ 18 years are randomly assigned into two groups after delivery in the Oulu university hospital. The study period begins 5-12 weeks after delivery. All participants will have conventional postpartum lifestyle counselling and the intervention group get in addition access for 12 months to web-based HBCSS application, which is recommended to use twice a week for 5-10 minutes. Participants are followed by questionnaires up to 24 months. The main outcome is weight change from baseline to 12 and 24 months. Medical records and national registers are used for long-term follow-up. Researchers have permission to contact participants afterwards. The ethical approval is permitted by the Regional Medical Research Ethics Committee of the Wellbeing Services County of North Ostrobothnia. The authorization for the use of medical device is granted from the Finnish Medicines Agency. Recruitment of the participants will be performed 2/2024-1/2026.

Interventions

DEVICEInformation and communication technology -based health behavior change support system

Information and communication technology -based health behavior change support system addition to conventional postpartum lifestyle education

Sponsors

University of Oulu
CollaboratorOTHER
Oulu University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized controlled study

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Pre-pregnancy BMI ≥ 30.0 kg/m\^2 * Smartphone user

Exclusion criteria

* Eating disorder * Severe mental disorder * Use of other lifestyle support system or medication * Non-Finnish speaker

Design outcomes

Primary

MeasureTime frameDescription
Weight change12 monthsWeight change in kilograms and change of body mass index (kg/m\^2)

Secondary

MeasureTime frameDescription
Weight change before subsequent pregnancy1-8 yearsWeight change in kilograms and change of body mass index (kg/m\^2)
Pregnancy disorders in subsequent pregnancy (gestational diabetes, pre-eclampsia, gestational hypertension, preterm delivery)1-8 yearsNumber of participants with pregnancy disorders in subsequent pregnancy (gestational diabetes, pre-eclampsia, gestational hypertension, preterm delivery, mortality)
Neonatal outcome in subsequent pregnancy (preterm birth, large for gestational age, small for gestational age, need for neonatal intensive care, mortality)1-8 yearsNumber of neonates with adverse neonatal outcome (preterm birth, large for gestational age, small for gestational age, need for neonatal intensive care, mortality)

Countries

Finland

Contacts

Primary ContactSanna Mustaniemi, PhD
sanna.mustaniemi@oulu.fi+358 8669 9500
Backup ContactElina Keikkala, PhD
elina.keikkala@oulu.fi

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026